4th Quarter - Report

VENN STRATEGIES for SAFE VISION ALLIANCE

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$10,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Termination Oct 20, 2014 $10,000 Replaced
4th Quarter - Report (this page) Jul 3, 2018 $10,000 Replaced
4th Quarter - Termination Amendment Sep 11, 2018 $10,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advocacy related to safety of vision therapies.

LobbyistCovered position, as disclosed
DAYLE LEWIS CRISTINZIO —
LAUREN RELIFORD —
STEPHANIE SILVERMAN —
SARA SKUBIKOWSKI —
BRADFORD TALLAMY —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.